Archive - September 2023
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
Combo Immunotherapy With Durvalumab Effective for NSCLC
Venatorx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI), including Pyelonephritis, in Adults
Waist-to-Hip Ratio Has Strongest Link With All-Cause Mortality
Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
Increased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis
Phathom Pharmaceuticals Announces Submission of Six-Month Stability Data in Support of Erosive GERD New Drug Application for Vonoprazan
Short-Term Survival Worse for Single-Ventricle Congenital Heart Disease Patients